Brain natriuretic peptide predicts functional outcome in ischemic stroke

scientific article published on 23 November 2011

Brain natriuretic peptide predicts functional outcome in ischemic stroke is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1161/STROKEAHA.111.629212
P932PMC publication ID3265658
P698PubMed publication ID22116811
P5875ResearchGate publication ID51830108

P50authorAlessandro BiffiQ91821855
Patrick T EllinorQ57775928
David M. GreerQ64136824
P2093author name stringNatalia S Rost
Karen L Furie
Lisa Cloonan
Peter Kelly
John Chorba
P2860cites workClassification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke TreatmentQ22306370
Predicting outcome in ischemic stroke: external validation of predictive risk modelsQ30310381
Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart AssociationQ30434464
Risk factors, outcome, and treatment in subtypes of ischemic stroke: the German stroke data bankQ30664833
Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials: Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITS-MOST).Q33377421
Mortality and predictors of death 1 month and 3 years after first-ever ischemic stroke: data from the first national acute stroke Israeli survey (NASIS 2004).Q33518989
Long-term functional recovery after first ischemic stroke: the Northern Manhattan StudyQ33697952
Gender differences in outcomes after ischemic stroke: role of ischemic lesion volume and intracranial large-artery occlusionQ34354508
Predicting functional outcome and survival after acute ischemic strokeQ34761089
Long-Term Outcome after Ischaemic Stroke/Transient Ischaemic AttackQ35108042
Race and gender differences in 1-year outcomes for community-dwelling stroke survivors with family caregiversQ35114083
Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the communityQ35575045
B-type natriuretic peptide: issues for the intensivist and pulmonologistQ36251643
Hyperlipidemia and reduced white matter hyperintensity volume in patients with ischemic strokeQ37208520
State of the art: using natriuretic peptide levels in clinical practiceQ37257460
N-terminal probrain natriuretic peptide predicts 1-year mortality following acute stroke: possible evidence of occult cardiac dysfunction among patients with acute strokeQ85040496
Blood markers for the prognosis of ischemic stroke: a systematic reviewQ37415033
Time to treatment and acute coronary syndromes: bridging the gap in rapid decision making.Q37779238
Thromboembolic complications in atrial fibrillationQ38140438
Factors affecting the B-type natriuretic peptide levels in stroke patientsQ43036265
Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers.Q43529232
Three-month stroke outcome: the European Registers of Stroke (EROS) investigatorsQ43988905
Concentrations of C-reactive protein and B-type natriuretic peptide 30 days after acute coronary syndromes independently predict hospitalization for heart failure and cardiovascular deathQ44279052
Inflammation, homocysteine, and vitamin B6 status after ischemic strokeQ44681253
Predicting outcome after acute ischemic stroke: an external validation of prognostic modelsQ47189349
Comparison of clinical characteristics and functional outcomes of ischemic stroke in different vascular territories.Q48113272
Serial biomarker measurements in ambulatory patients with chronic heart failure: the importance of change over timeQ48126208
Plasma brain natriuretic peptide predicts death during hospitalization in acute ischaemic stroke and transient ischaemic attack patients with atrial fibrillationQ48174572
Rate, degree, and predictors of recovery from disability following ischemic strokeQ48176169
The real estate factor: quantifying the impact of infarct location on stroke severityQ48360959
Atrial fibrillation after acute strokeQ48365357
High-sensitivity C-reactive protein, lipoprotein-associated phospholipase A2, and outcome after ischemic strokeQ48389128
Influence of stroke survivor characteristics and family conflict surrounding recovery on caregivers' mental and physical healthQ48509999
B-type natriuretic peptide: a strong predictor of early and late mortality in patients with acute chest pain without ST-segment elevation in the emergency departmentQ48701295
A three-item scale for the early prediction of stroke recovery.Q48819164
Brain natriuretic peptide as a surrogate marker for cardioembolic stroke with paroxysmal atrial fibrillationQ48921662
Guidelines for the early management of patients with ischemic stroke: 2005 guidelines update a scientific statement from the Stroke Council of the American Heart Association/American Stroke AssociationQ48948869
Auckland Stroke Outcomes Study. Part 1: Gender, stroke types, ethnicity, and functional outcomes 5 years poststroke.Q48971062
A computerized algorithm for etiologic classification of ischemic stroke: the Causative Classification of Stroke System.Q51905089
Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrationsQ73736775
NT-pro-BNP is associated with long-term outcome in a heterogeneous sample of cardiac inpatientsQ80194349
Cardiac troponins and N-terminal pro-brain natriuretic peptide in acute ischemic stroke do not relate to clinical prognosisQ81158100
Discordant atrial natriuretic peptide and brain natriuretic peptide levels in lone atrial fibrillationQ81223583
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectbrain natriuretic peptideQ66360952
P304page(s)441-445
P577publication date2011-11-23
P1433published inStroke JournalQ7624282
P1476titleBrain natriuretic peptide predicts functional outcome in ischemic stroke
P478volume43

Reverse relations

cites work (P2860)
Q48552186Acute Ischemic Stroke Severity, Progression, and Outcome Relate to Changes in Dipeptidyl Peptidase IV and Fibroblast Activation Protein Activity.
Q36642014Amino terminal pro-B-type natriuretic peptide, secondary stroke prevention, and choice of antithrombotic therapy
Q44304248Aortic stiffness and plasma brain natriuretic peptide predicts mortality in acute ischemic stroke
Q55100653Associated Factors with Left Atrial Enlargement in Patients with Acute Ischemic Stroke.
Q40347969Association Between Subclinical Cardiac Biomarkers and Clinically Manifest Cardiac Diseases With Cortical Cerebral Microinfarcts
Q26861828B-type natriuretic peptides and mortality after stroke: a systematic review and meta-analysis
Q33967122BNP but Not s-cTnln is associated with cardioembolic aetiology and predicts short and long term prognosis after cerebrovascular events
Q27004404Biomarkers for stroke
Q95492624Brain Natriuretic Peptide Is a Powerful Predictor of Outcome in Stroke Patients with Atrial Fibrillation
Q48360592Brain natriuretic peptide is associated with worsening and mortality in acute stroke patients but adds no prognostic value to clinical predictors of outcome.
Q92126943Brain-heart interaction after acute ischemic stroke
Q37273542C-reactive protein and B-type natriuretic peptide yield either a non-significant or a modest incremental value to traditional risk factors in predicting long-term overall mortality in older adults
Q33715302Cardiac Natriuretic Peptides, Hypertension and Cardiovascular Risk
Q38188010Cardioembolic stroke diagnosis using blood biomarkers
Q35193631Difference in the prognostic significance of N-terminal pro-B-type natriuretic peptide between cardioembolic and noncardioembolic ischemic strokes
Q89820429Dynamic Changes and Prognostic Value of Gut Microbiota-Dependent Trimethylamine-N-Oxide in Acute Ischemic Stroke
Q36152775Markers of cardiac dysfunction in cognitive impairment and dementia
Q36383798N-terminal pro-brain natriuretic peptide levels and short term prognosis in acute ischemic stroke
Q38270771Neuroendocrine hormones as prognostic biomarkers in the setting of acute stroke: overcoming the major hurdles.
Q41921395Opinions about the use of brain natriuretic peptide among acute ischemic stroke patients
Q41485181Quality of life predictors in chronic stable post-stroke patients and prognostic value of SF-36 score as a mortality surrogate
Q36607714Risk factors for pulmonary hypertension in patients receiving maintenance peritoneal dialysis
Q92346175Serum B-type natriuretic peptide level and timing of its measurement as a predictor of acute ischemic stroke outcome
Q47733196Serum N-terminal proBNP, not troponin I, at presentation predicts long-term neurologic outcome in acute charcoal-burning carbon monoxide intoxication.
Q41357862Soluble ST2 predicts outcome and hemorrhagic transformation after acute stroke
Q64093570Stroke Dysbiosis Index (SDI) in Gut Microbiome Are Associated With Brain Injury and Prognosis of Stroke
Q26849846Stroke rehabilitation: recent advances and future therapies
Q48695759Stroke: Brain natriuretic peptide could be a biomarker for outcomes after cardioembolic stroke
Q36733964Troponin T, N-terminal pro-B-type natriuretic peptide, and incidence of stroke: the atherosclerosis risk in communities study

Search more.